Follow The Filings

ENSG Ensign Group Inc.

Health Care, filed as ENSIGN GROUP INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2

  • 1 Owner
  • Max 0.0%
  • $10M
  • 1 add

In 2026 Q2 First Eagle Investment Management added to Ensign Group.

Who owns this now

Largest portfolio weights among holders, up to 0.0% (First Eagle Investment Management). Not free-float ownership.

  1. First Eagle Investment Manage... Add 0.02%

Who owns ENSG

Sorted by value, long equity only, as of 2026 Q2.

History
First Eagle Investment Management 0.02% Add +5080.4% 64,600 $10M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by ENSG's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ENSG insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • $13.6M sold by 9 insiders under 10b5-1 plans
  1. Mark Vincent Parkinson Director
    Planned sale
    $18K 100 shares at $179.62 2.2% of stake
    Traded Oct 16 Filed Oct 19
    ↗
  2. Ann Scott Blouin Director
    Planned sale
    $69K 375 shares at $183.54 1.6% of stake
    Traded Jul 27 Filed Jul 29
    ↗
  3. John O Agwunobi Director
    Planned sale
    $67K 392 shares at $171.06 4% of stake
    Traded Jul 20 Filed Jul 22
    ↗
  4. Mark Vincent Parkinson Director
    Planned sale
    $17K 100 shares at $168.12 2.5% of stake
    Traded Jul 16 Filed Jul 17
    ↗
  5. Barry M Smith Director
    Planned sale
    $115K 700 shares at $164.28 3.2% of stake
    Traded Jun 2 Filed Jun 4
    ↗
  6. Barry M Smith Director
    Planned sale
    $128K 700 shares at $182.21 3.1% of stake
    Traded May 4 Filed May 6
    ↗
  7. John O Agwunobi Director
    Planned sale
    $78K 392 shares at $199.97 4% of stake
    Traded Apr 20 Filed Apr 22
    ↗
  8. Mark Vincent Parkinson Director
    Planned sale
    $20K 100 shares at $196.60 2.9% of stake
    Traded Apr 16 Filed Apr 17
    ↗
  9. Barry M Smith Director
    Planned sale
    $138K 700 shares at $196.65 3.1% of stake
    Traded Apr 2 Filed Apr 6
    ↗
  10. Barry M Smith Director
    Planned sale
    $149K 700 shares at $213.02 3% of stake
    Traded Mar 2 Filed Mar 2
    ↗
  11. Beverly B. Wittekind VP and Chief Legal Officer
    Planned sale
    $105K 500 shares at $210.23 1.5% of stake
    Traded Feb 19 Filed Feb 20
    ↗
  12. Daren Shaw Director
    Planned sale
    $213K 1,000 shares at $213.43 4% of stake
    Traded Feb 17 Filed Feb 19
    ↗
  13. Mark Vincent Parkinson Director
    Planned sale
    $20K 100 shares at $198.00 3.3% of stake
    Traded Feb 9 Filed Feb 9
    ↗
  14. Ann Scott Blouin Director
    Planned sale
    $74K 375 shares at $198.00 1.6% of stake
    Traded Feb 9 Filed Feb 9
    ↗
  15. Suzanne D. Snapper CFO
    Planned sale
    $2.5M 12,831 shares at $195.06 4.5% of stake
    Traded Feb 5–6 Filed Feb 9
    ↗

Also filed in the last 12 months, not counted as buying or selling: 34 stock grants, 23 share withholdings for taxes, 12 option exercises, 6 gifts, and 3 sales to cover taxes.

SEC filings

Recent issuer filings from EDGAR, 11 shown.

Filed Form Detail Links
8-K 5.03,9.01 Filing Doc
8-K 1.01,2.03,7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 8.01 Filing Doc
8-K 5.07 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 4 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $3.73B $4.26B $5.03B
Gross profit * $0.788B $0.884B $1.01B
Gross margin * 21.1% 20.7% 20.1%
Net income $209.4M $297.97M $343.97M
Net margin * 5.6% 7.0% 6.8%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $1.05B $1.16B $1.27B
Total non-current assets * $3.13B $3.51B $4.19B
Total assets $4.18B $4.67B $5.46B
Total current liabilities $734.75M $743.43M $894.35M
Total non-current liabilities * $1.95B $2.09B $2.33B
Total equity $1.49B $1.84B $2.23B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $376.67M $347.19M $564.27M
Cash from investing -$182.7M -$390.05M -$513.18M
Cash from financing -$0.612M -$2.16M -$11.81M
Net change in cash $193.36M -$45.03M $39.28M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.